Neuropathic Pain Therapeutics Summit
August 24 - 25, 2021 - KS USHanson Wade
info@hansonwade.com
Phone:+16174554188
The First Industry-Dedicated Conference Focused on Accelerating Novel Neuropathic Pain Therapeutics into the Clinic. The opioid crisis rages on unabated. Meanwhile, the global population continues to age, creating an enormous need for next-generation neuropathic pain treatment and management approaches. This has stimulated a renewed sense of urgency to discover, translate and accelerate non-addictive and clinically effective pain relief therapeutics into the clinic and to patients in pain. As such, the Neuropathic Pain Therapeutics Digital Summit arrives as the first-ever industry dedicated meeting for large pharma, biotech and academia, to discover novel, non-addictive neuropathic pain therapeutic mechanisms of action. Expect to be involved in interactive discussions on the diversity of next-generation neuropathic pain drugs in development including NaV1.7 channel inhibitors, antisense oligonucleotides, matrix metalloproteinase inhibitors, gene therapy, anti-TRPV1 antibody, cannabinoid-derived pharmaceutical, neuroimmune targeted, medical device approaches, and more! This is your chance to understand the latest findings on the underlying pathophysiology of neuropathic pain. Overcome preclinical model challenges to identify pain biomarkers and harness the neuroimmune axis to tackle neuropathic pain and discuss novel pharmacological approaches along the neuropathic pain patient continuum of care. The time is now to shape the future fabric of neuropathic pain drug development and to make a meaningful dent on the opioid crisis. Make sure to be part of this unique forum to strengthen your pipeline of neuropathic pain therapeutics and accelerate them into the clinic and to patients in need. Group discounts and early booking rates are available. Please visit the website for full pricing information www.neuropathic-pain-therapeutics.com